Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007 | Zendy

M.J. Ellington | Zendy; Russell Hope | Zendy; David M. Livermore | Zendy; Angela Kearns | Zendy; Katrina Henderson | Zendy; B. Cookson | Zendy; A. Pearson | Zendy; Alan P. Johnson | Zendy

Open Access

Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007

Author(s) -

M.J. Ellington,

Russell Hope,

David M. Livermore,

Angela Kearns,

Katrina Henderson,

B. Cookson,

A. Pearson,

Alan P. Johnson

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkp448

Subject(s) - staphylococcus aureus , microbiology and biotechnology , methicillin resistant staphylococcus aureus , medicine , biology , bacteria , genetics

Between 1998 and 2000, 95.6% of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemias in the UK were due to two epidemic strains, namely EMRSA-15 or EMRSA-16 (60.2% and 35.4%, respectively). We sought to determine the proportions of these strains before and after the general decline in MRSA bacteraemia that began around 2004.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research